Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions

British Journal of Haematology

Volumn 168, Issue 3, 2015, Pages 443-451

  Verduin, Esther P ^a,b   Brand, Anneke ^b   van de Watering, Leo M G ^a,b   Claas, Frans H J ^b   Oepkes, Dick ^b   Lopriore, Enrico ^b   Doxiadis, Ilias I N ^b   Schonewille, Henk ^a,b  

^a SANQUIN RESEARCH   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alloimmunization; Antibody persistence; Chimerism; Haemolytic disease of the fetus and newborn; Red blood cell

Indexed keywords

ERYTHROCYTE ANTIBODY; MACROGOL; RHESUS ANTIBODY; ALLOANTIBODY; ALLOANTIGEN; RHO(D) ANTIBODY;

ADULT; ALLOIMMUNIZATION; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CHILD; CHIMERA; CONTROLLED STUDY; FEMALE; FETOMATERNAL TRANSFUSION; HEMOLYTIC ANEMIA; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; MALE; NEWBORN HEMOLYTIC DISEASE; OBSERVATIONAL STUDY; PREGNANCY; SALIVA ANALYSIS; TWIN PREGNANCY; ADOLESCENT; BLOOD; ERYTHROBLASTOSIS, FETAL; ERYTHROCYTE; FOLLOW UP; IMMUNOLOGY; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD TRANSFUSION, INTRAUTERINE; CHILD; CHILD, PRESCHOOL; CHIMERISM; ERYTHROBLASTOSIS, FETAL; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; ISOANTIBODIES; ISOANTIGENS; MIDDLE AGED; PREGNANCY; YOUNG ADULT;

EID: 84921326160     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13130     Document Type: Article

References (35)

1. Amanna, I.J., Carlson, N.E. & Slifka, M.K. (2007) Duration of humoral immunity to common viral and vaccine antigens. New England Journal of Medicine, 357, 1903-1915.
2. Bianchi, D.W., Zickwolf, G.K., Weil, G.J., Sylvester, S. & DeMaria, M.A. (1996) Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proceedings of the National Academy of Sciences of the United States of America, 93, 705-708.
3. Chu, V.T. & Berek, C. (2013) The establishment of the plasma cell survival niche in the bone marrow. Immunological Reviews, 251, 177-188.
4. Ekström, N., Ahman, H., Palmu, A., Grönholm, S., Kilpi, T., Käyhty, H. & FinOM Study Group. (2013) Concentration and high avidity of pneumococcal antibodies persist at least 4 years after immunization with pneumococcal conjugate vaccine in infancy. Clinical and Vaccine Immunology, 20, 1034-1040.
5. Hoch, J., Giers, G., Bald, R., Hansmann, M. & Hanfland, P. (1993) Antibody induction after intrauterine interventions. Infusionstherapie und Transfusionsmedizin, 20(Supplement 2), 70-73.
6. Hutchison, H.E. & McLennan, W. (1966) Long persistence of rhesus antibodies. Vox Sanguinis, 11, 517-518.
7. Janssens, H.M., de Haan, M.J., van Kamp, I.L., Brand, R., Kanhai, H.H. & Veen, S. (1997) Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism. Journal of Pediatrics, 131, 373-380.
8. van Kamp, I.L., Klumper, F.J., Meerman, R.H., Oepkes, D., Scherjon, S.A. & Kanhai, H.H. (2004) Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. Acta Obstetrica et Gynecologica Scandinavica, 83, 731-737.
9. van Kamp, I.L., Klumper, F.J., Oepkes, D., Meerman, R.H., Scherjon, S.A., Vandenbussche, F.P. & Kanhai, H.H. (2005) Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. American Journal of Obstetrics and Gynecology, 192, 171-177.
10. Lee, T.H., Paglieroni, T., Utter, G.H., Chafets, D., Gosselin, R.C., Reed, W., Owings, J.T., Holland, P.V. & Busch, M.P. (2005) High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion, 45, 1280-1290.
11. Nelson, J.L. (2002) Microchimerism: incidental byproduct of pregnancy or active participant in human health? Trends in Molecular Medicine, 8, 109-113.
12. Ness, P.M., Shirey, R.S., Thoman, S.K. & Buck, S.A. (1990) The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion, 30, 688-693.
13. Owen, R.D., Wood, H.R., Foord, A.G., Sturgeon, P. & Baldwin, L.G. (1954) Evidence for acitively acquired tolerance to Rh antigens. Proceedings of the National Academy of Sciences of the United States of America, 40, 420-424.
14. Palfi, M. & Gunnarsson, C. (2001) The frequency of anti-C + anti-G in the absence of anti-D in alloimmunized pregnancies. Transfusion Medicine, 11, 207-210.
15. Pichichero, M.E. (2009) Booster vaccinations; can immunologic memory outpace disease pathogenesis. Pediatrics, 124, 1633-1641.
16. Pineda, A.A., Vamvakas, E.C., Gorden, L.D., Winters, J.L. & Moore, S.B. (1999) Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion, 39, 1097-1103.
17. Ramsey, G. & Larson, P. (1988) Loss of red cell alloantibodies over time. Transfusion, 28, 162-165.
18. Ramsey, G. & Smietana, S.J. (1994) Long-term follow-up testing of red cell alloantibodies. Transfusion, 34, 122-124.
19. Reed, M. & Lomas-Francis, C. (2007) The Blood Group Antigen Facts book, 2nd edn. Academic Press, London, UK.
20. Reverberi, R. (2008) The persistence of red cell alloantibodies. Blood Transfusion, 6, 225-234.
21. Rosse, W.F., Gallagher, D., Kinney, T.R., Castro, O., Dosik, H., Moohr, J., Wang, W. & Levy, P.S. (1990) Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood, 76, 1431-1437.
22. Rossi, G. (2004) Nature of stem cell involved in fetomaternal microchimerism. Lancet, 364, 1936.
23. Schonewille, H., Haak, H.L. & van Zijl, A.M. (2000) RBC antibody persistence. Transfusion, 40, 1127-1131.
24. Schonewille, H., Klumper, F.J., van de Watering, L.M., Kanhai, H.H. & Brand, A. (2007) High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus. American Journal of Obstetrics and Gynecology, 196, 143-146.
25. Schonewille, H., Doxiadis, I.I., Levering, W.H., Roelen, D.L., Claas, F.H. & Brand, A. (2014) HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies. Transfusion, 54, 1971-1980.
26. Shirey, R.S., Mirabella, D.C., Lumadue, J.A. & Ness, P.M. (1997) Differentiation of anti-D, -C, and -G: clinical relevance in alloimmunized pregnancies. Transfusion, 37, 493-496.
27. Sunku Cuddapah, CS, Gadi, VK, de Laval de Lacoste, B, Guthrie, KA & Nelson, JL. (2010) Maternal and fetal microchimerism in granulocytes. Chimerism, 1, 11-14.
28. Tangye, S.G. (2011) Staying alive: regulation of plasma cell survival. Trends in Immunology, 32, 595-602.
29. Tormey, C.A. & Stack, G. (2009) The persistence and evanescence of blood group alloantibodies in men. Transfusion, 49, 505-512.
30. Utter, G.H., Lee, T.H., Rivers, R.M., Montalvo, L., Wen, L., Chafets, D.M., Reed, W.F. & Busch, M.P. (2008) Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts. Transfusion, 48, 1609-1615.
31. Verduin, E.P., Lindenburg, I.T., Smits-Wintjens, V.E., van Klink, J.M., Schonewille, H., van Kamp, I.L., Oepkes, D., Walther, F.J., Kanhai, H.H., Doxiadis, I.I., Lopriore, E. & Brand, A. (2010) LOng Term follow up after intra-Uterine transfusionS; the LOTUS study. BMC Pregnancy and Childbirth, 10, 77.
32. Vietor, H.E., Kanhai, H.H. & Brand, A. (1994) Induction of additional red cell alloantibodies after intrauterine transfusions. Transfusion, 34, 970-974.
33. Ward, H.K., Walsh, R.J. & Koopzoff, O. (1957) Rh antigens and immunological tolerance. Nature, 179, 1352-1353.
34. Watson, W.J., Wax, J.R., Miller, R.C. & Brost, B.C. (2006) Prevalence of new maternal alloantibodies after intrauterine transfusion for severe Rhesus disease. American Journal of Perinatology, 23, 189-192.
35. Winters, J.L., Richa, E.M., Bryant, S.C., Tauscher, C.D., Bendix, B.J. & Stubbs, J.R. (2010) Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactions. Transfusion, 50, 1444-1452.